US Corporate Board Director Changes SEC Filings — September 23, 2026

USA Board Room Changes

By Gunpowder Editorial ·

26 high priority 26 total filings analysed

Executive Summary

The 26 filings for September 23, 2026, reveal a significant wave of board and C-suite transitions, with a notable pattern of former CFOs and seasoned financial leaders moving into board roles (Farmers & Merchants Bancshares, Five Below, MeiraGTx).

The most material event is TransUnion's CFO departure, which is partially mitigated by reaffirmed guidance, while Angi's CEO appointment of Michael Steib signals a strategic pivot toward AI-driven growth. A cluster of biotech and tech companies (MeiraGTx, Flywire, Corcept) are adding directors with deep capital markets and operational expertise, suggesting a focus on commercial readiness. The absence of negative insider selling or guidance cuts across the filings is a positive signal, though several retirements (Boston Scientific, PRA Group, Plug Power) create near-term execution risk. Overall, the digest points to a healthy governance refresh cycle with a tilt toward experienced operators and capital allocators, but investors should monitor the CFO transitions at TransUnion and Galaxy Digital for potential disruption.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K

Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from September 21, 2026.

Investment Signals (10)

  • Angi Inc. ↓ (BULLISH)
    ▲

    Appointed Michael Steib (former TEGNA CEO) as CEO; under his leadership at XO Group, stock tripled before merger. Focus on AI-driven growth suggests potential for operational turnaround and margin expansion

  • ▲

    CFO Todd Cello (29-year veteran) departs Dec 31, 2026, but company reaffirmed Q3 and full-year 2026 guidance for revenue, Adjusted EBITDA, and Adjusted Diluted EPS. This provides a 3-month transition buffer, reducing near-term risk

  • Appointed Alan M. Sebulsky (former $2B biopharma portfolio manager at Adage Capital) to board as company transitions to commercial stage. His capital markets expertise could unlock strategic partnerships or financing

  • CEO granted $10M PSU award with stock price hurdles ($40-$100) over 4 years, but 50% reduction if TSR falls below 55th percentile of S&P 1500 Consumer Discretionary Index. Aligns management with aggressive shareholder value creation

  • ▲

    Appointed Sabrina Farmer (former GitLab CTO, Google VP Engineering) to board. Her deep tech expertise could accelerate product innovation and AI integration in payments

  • ▲

    Appointed Scott Settersten (former Ulta Beauty CFO, 15 years at PwC) to board and audit committee. His retail scaling experience is valuable as Five Below navigates growth and margin pressures

  • President of Endocrinology retiring, replaced by Justin Gunn who built sales organization for Lifyorli (approved for platinum-resistant ovarian cancer). Signals potential expansion beyond Cushing's syndrome

  • Largest shareholder Apeiron Investment Group increasing stake continuously; new board includes gaming/esports expert Mike Sepso. Insider accumulation is a strong vote of confidence

  • Shareholders approved reverse stock split (1:5 to 1:20) with 98% support. This could improve listing compliance and attract institutional investors, but risks dilutive perception [NEUTRAL/BULLISH]

  • ▲

    COO resigning effective Oct 23, 2026 to join another company. No disagreement cited, but loss of a key operational leader amid hydrogen sector challenges is a concern

Risk Flags (9)

  • ▼

    CFO Todd Cello (29-year tenure, 9 as CFO) leaving at year-end. While guidance is reaffirmed, the loss of institutional knowledge and the CFO search process create execution risk, especially if a replacement isn't found quickly

  • COO Dean Fullerton resigning effective Oct 23 to join another company. With duties being transitioned to multiple EVPs/VPs, there's risk of operational disruption during a critical period for hydrogen economy scaling

  • Bath & Body Works/PSU Risk↓ [LOW-MEDIUM RISK]
    ▼

    CEO's $10M PSU award has a 50% reduction clause if TSR falls below 55th percentile of S&P 1500 Consumer Discretionary Index. This introduces potential for significant compensation clawback if relative performance lags

  • Chief Accounting Officer Robert Rico resigning effective Sept 30, replaced by internal Head of Accounting Policy. Transition risk in crypto accounting complexity, though internal hire suggests continuity

  • Reverse stock split authorized (1:5 to 1:20) but ratio not yet determined. If aggressive ratio is chosen, it could signal distress and trigger selling pressure from retail investors

  • CEO Kewei Huang resigning for health reasons; replaced by Sheng-Yih Chang who previously served as CEO (April-Sept 2026). This is the second CEO change in 6 months, indicating instability

  • Tivic Health Systems (Valion Bio)/CEO Transition [MEDIUM RISK]
    ▼

    CEO Sheryle Bolton stepped down from board; Dean Zikria appointed Interim CEO. Interim titles often signal ongoing search and potential strategic uncertainty

  • Amended bylaws eliminate stockholder action by written consent, reducing shareholder power. This could be perceived as entrenchment by activist investors

  • President of PRA Group Europe retiring Dec 31, 2026. Europe is a key growth region for debt purchasing; transition risk if replacement isn't seasoned

Opportunities (9)

  • ◆

    New CEO Michael Steib (former TEGNA CEO, XO Group where stock tripled) brings AI-driven growth focus. With shares likely depressed post-spinoff, this could be a turnaround play. Monitor Q3 earnings for initial strategy details

  • Appointment of Alan Sebulsky (managed $2B biopharma portfolio) as company nears commercial stage with 4 late-stage programs. His network could facilitate partnerships or M&A. Trading at potential discount to pipeline value

  • Guidance reaffirmed despite CFO departure, suggesting strong underlying business. If market overreacts to departure, could create buying opportunity. CFO search completion could be a positive catalyst

  • Largest shareholder Apeiron Investment Group continuously increasing stake. New board includes gaming expert Mike Sepso. This could signal impending value-creating transaction or operational improvements

  • Sabrina Farmer's GitLab/Google experience could drive AI and product innovation in payments. With cross-border education payments growing, this board refresh could accelerate growth

  • ◆

    Scott Settersten's Ulta Beauty CFO experience (2012-2024) brings scaling expertise. Five Below has growth ambitions; his operational finance background could improve capital allocation and margin management

  • New Endocrinology head Justin Gunn built successful sales organization for Lifyorli. This could signal preparation for new product launch or expansion beyond Cushing's. Watch for pipeline updates

  • Board expanded for pending merger with Southern Realty Trust (expected Q4 2026). Combined entity could create scale benefits. Monitor merger closing and post-merger strategy

  • 4M share 2026 Equity Incentive Plan approved, replacing expired 2016 plan. This enables talent retention and acquisition, crucial for growth-stage company. Auditor ratification with 98% support shows shareholder alignment

Sector Themes (5)

  • Former CFOs to Board Seats
    ◆

    Three companies (Farmers & Merchants Bancshares, Five Below, MeiraGTx) appointed former CFOs or financial leaders to boards. This trend suggests companies are prioritizing financial discipline and capital markets expertise in governance, particularly as rate uncertainty persists

  • Biotech Commercialization Readiness
    ◆

    MeiraGTx (portfolio manager), Corcept (new commercial leader), and Tivic Health (interim CEO with Pfizer experience) are adding talent with commercial-stage experience. This cluster suggests the sector is preparing for product launches and revenue generation after years of R&D focus

  • Tech/Fintech Board Refresh
    ◆

    Flywire (ex-GitLab CTO), Angi (AI-focused CEO), and Enhanced Group (gaming expert) are adding digital-native leaders. This reflects a broader push to integrate AI and platform capabilities into traditional business models

  • Orderly C-Suite Transitions with Advisory Periods
    ◆

    Multiple filings (Boston Scientific, TransUnion, PRA Group, Corcept) include 2-3 month advisory periods after executive departures. This structured transition approach reduces execution risk compared to abrupt departures, signaling mature governance practices

  • Shareholder Democracy in Action
    ◆

    OneMedNet (98% support for reverse split) and LiveOne (98% auditor ratification) show strong shareholder alignment. However, Vertical Data's elimination of written consent could spark governance debates. Overall, companies are seeking shareholder approval for key decisions, which is positive for governance

Watch List (8)

  • CFO departing Dec 31, 2026; search initiated with leading firm. Quality and speed of replacement will signal stability. Watch for Q3 earnings call (likely late Oct) for updates on search and any guidance changes [Date: Q3 2026 earnings]

  • Michael Steib starts immediately; watch for first strategic update (likely Q3 earnings) on AI initiatives and profitability targets. His track record at XO Group (stock tripled) sets high expectations [Date: Q3 2026 earnings]

  • COO resigns Oct 23; duties split among EVPs/VPs. Monitor for any operational disruptions or missed milestones in hydrogen projects. Next earnings call will be key for transition update [Date: Oct 23, 2026]

  • Board authorized 1:5 to 1:20 ratio but hasn't selected. Announcement of specific ratio will be a catalyst. Watch for Nasdaq compliance updates [Date: TBD]

  • Merger with Southern Realty Trust expected Q4 2026. Board expansion contingent on closing. Monitor for regulatory approvals and shareholder votes [Date: Q4 2026]

  • New Corporate Controller Dritan Muneka starts Sept 30. With crypto accounting complexity, watch for any restatements or filing delays in subsequent quarters [Date: Sept 30, 2026]

  • Second CEO change in 6 months. Monitor for further board changes or strategic shifts. Watch for 8-K filings regarding additional departures [Date: Ongoing]

  • Tivic Health Systems (Valion Bio)/Interim CEO
    👁

    Dean Zikria as Interim CEO; watch for permanent CEO appointment and strategic direction for Entolimod program. Next catalyst could be clinical data readout [Date: TBD]

Filing Analyses (26)
Vertical Data Inc. 8-K neutral materiality 3/10

23-09-2026

Vertical Data Inc. filed an 8-K on September 23, 2026, disclosing amended and restated bylaws (Exhibit 3.1) that update governance procedures including stockholder meetings, voting, director nominations, and remote participation. The filing also covers items related to unregistered equity sales, officer changes, and amendments to articles, but the primary substantive disclosure is the adoption of the new bylaws. No financial figures or period-over-period comparisons are included in this filing.

  • · The amended bylaws eliminate stockholder action by written consent (Section 12).
  • · Quorum is set at one-third of outstanding shares entitled to vote (Section 6).
  • · Director elections require a plurality vote; other matters require a majority of shares present (Section 10).
  • · Stockholder nominations for directors are restricted to those made by the Board or by stockholders who comply with advance notice procedures (Section 14).
  • · The Board, CEO, or Chair may postpone, reschedule, or cancel any previously scheduled stockholder meeting (Sections 2 & 3).
BOSTON SCIENTIFIC CORP 8-K neutral materiality 3/10

23-09-2026

Boston Scientific announced that Executive Vice President and Group President, MedSurg and Asia Pacific, Arthur C. Butcher, will retire effective January 1, 2027, and remain as a senior advisor through February 26, 2027. He will receive a prorated base salary of $780,000 during the advisory period. The company expects to enter into a retirement agreement with materially consistent benefits under existing plans.

  • · Retirement effective date: January 1, 2027
  • · Senior advisor period ends February 26, 2027 (Retirement Date)
  • · Retirement Agreement benefits are materially consistent with Executive Retirement Plan, 2026 Annual Bonus Plan, and Long-Term Incentive Program
Terra Innovatum Global N.V. 8-K neutral materiality 5/10

23-09-2026

Terra Innovatum Global N.V. (NKLR) announced the resignation of three directors (Rex Jackson, Michael Howard, and Peter Hastings) effective September 17, 2026, and the appointment of three new independent directors (Tony Tullio, Michael Modro, and Kostadin Ivanov) effective September 22, 2026. Peter Hastings will transition to a consulting role supporting commercialization efforts. The new directors will enter into standard indemnification agreements. No financial figures or performance metrics were disclosed.

  • · The resignations and appointments were effective on September 17 and September 22, 2026, respectively.
  • · Peter Hastings will support the Company’s ongoing commercialization efforts and related strategic initiatives in a consulting role.
  • · Tony Tullio was appointed interim chairman of the Board’s Audit Committee and as a member of the Board’s Remuneration Committee.
  • · Each of the Resigning Directors and Independent Directors are expected to enter into an indemnification agreement with the Company.
  • · The Company is an emerging growth company as defined under the Securities Act.
Angi Inc. 8-K positive materiality 6/10

23-09-2026

Angi Inc. appointed Michael Steib as CEO, succeeding Jeff Kip, effective immediately. Joey Levin transitions from Executive Chairman to Chairman. Steib, former CEO of TEGNA and XO Group, brings a focus on AI-driven growth and profitability. Kip will serve as an advisor for six months to ensure a smooth transition.

  • · Michael Steib was most recently president and CEO of TEGNA, which was acquired by Nexstar Media Group at a substantial premium in March 2026.
  • · At XO Group, the company's stock tripled under Steib's leadership before it merged with WeddingWire Inc.
  • · Jeff Kip will serve as advisor to the company for six months.
  • · Angi was founded in 1995 and has helped homeowners with more than 300 million projects.
Flywire Corp 8-K positive materiality 5/10

23-09-2026

Flywire Corp announced the appointment of Sabrina Farmer, former GitLab CTO and Google VP of Engineering, to its Board of Directors, effective September 23, 2026. Ms. Farmer brings over 25 years of technology leadership and will also join the Nominating and Corporate Governance Committee. The filing contains no financial results or period-over-period comparisons, so no quantitative performance data is available.

Bath & Body Works, Inc. 8-K neutral materiality 5/10

23-09-2026

Bath & Body Works granted CEO Daniel Heaf a performance stock unit award with a target value of $10 million (591,366 shares) on September 21, 2026. The PSU Award ties vesting to four stock price hurdles ($40, $60, $80, $100) over a four-year period, with potential payouts ranging from 75% to 200% of target. However, earned PSUs are subject to a 50% reduction if the company's total shareholder return falls below the 55th percentile of the S&P 1500 Consumer Discretionary Distribution & Retail Index at the end of the period, introducing a relative underperformance risk.

  • · The PSU Award is subject to a 50% reduction if the company's total shareholder return relative to the S&P 1500 Consumer Discretionary Distribution & Retail Index is below the 55th percentile at the end of the four-year performance period.
  • · The award agreement is filed as Exhibit 10.1 to the 8-K.
Farmers & Merchants Bancshares, Inc. 8-K neutral materiality 3/10

23-09-2026

Farmers & Merchants Bancshares, Inc. (FMFG) announced the election of Mark C. Krebs, the former CFO (retired June 30, 2025), to its Board of Directors (Class I) and the board of its wholly-owned subsidiary, Farmers and Merchants Bank, effective September 21, 2026. Mr. Krebs will serve until the 2027 annual meeting and has been appointed to the Asset/Liability, Investor Relations, and Nominating Committees. He will receive standard non-employee director compensation, and no new related-party transactions were disclosed.

  • · Mr. Krebs served as Treasurer and CFO from August 2016 until retirement on June 30, 2025.
  • · He served as an advisor to the Board from September 15, 2025 until his election.
  • · He will serve on the Asset/Liability, Investor Relations, and Nominating Committees.
  • · No reportable related-party transactions under Item 404(a) occurred since the start of FY2024.
HEALTHSTREAM INC 8-K neutral materiality 4/10

23-09-2026

HealthStream, Inc. approved special grants of Time-Based and Performance-Based RSUs to its named executive officers on September 18, 2026, to incentivize future performance and retention. The grants include 15,395 Time-Based RSUs (grant date fair value $450,000 each) to four executives and 12,316 Time-Based RSUs ($360,000) to the CFO, along with Performance-Based RSUs of 5,132 ($150,000 each) to four executives and 4,105 ($120,000) to the CFO. The awards vest over four years, with performance-based units tied to annual targets from 2027 to 2030.

  • · Time-Based RSUs vest in equal annual installments of 25% on the first, second, third, and fourth anniversaries of the grant date.
  • · Performance-Based RSUs vest in equal increments of 25% based on achievement of annual performance targets for 2027, 2028, 2029, and 2030.
  • · The grants were approved by the Compensation Committee of the Board of Directors.
FIVE BELOW, INC 8-K neutral materiality 30/10

23-09-2026

Five Below appointed Scott Settersten, former CFO of Ulta Beauty, to its Board of Directors and Audit Committee, effective September 21, 2026, expanding the board to ten directors. The appointment brings a seasoned finance leader with retail scaling experience, though no financial metrics or performance changes were disclosed in this filing.

  • · Scott Settersten served as CFO of Ulta Beauty from 2012 to March 2024.
  • · Settersten spent 15 years at PricewaterhouseCoopers LLP as a CPA.
  • · He served as a director and audit committee member of Kimball International from July 2020 to June 2023.
  • · Five Below has over 2,000 stores in 47 states.
Hartford Creative Group, Inc. 8-K neutral materiality 3/10

23-09-2026

Hartford Creative Group, Inc. announced the resignation of Kewei Huang as CEO and Chairman effective September 21, 2026, due to health reasons, with no disagreement with the company. Sheng-Yih Chang has been appointed as the new CEO and Chairman, effective the same date; Chang previously served as CEO from April 1, 2024 to September 1, 2026, and will receive no additional compensation for his re-appointment.

  • · Mr. Huang's resignation was effective September 21, 2026.
  • · Mr. Chang previously served as CEO from April 1, 2024 through September 1, 2026 and as CFO from June 2018 through April 1, 2024.
  • · Mr. Chang has been General Manager at Hartford Hotel since March 2018.
  • · Mr. Chang holds a Bachelor of Science in Electrical Engineering from California State University, Northridge.
  • · Mr. Chang's compensation remains unchanged from his prior CEO package; he will not receive additional compensation solely for re-appointment.
PRA GROUP INC 8-K neutral materiality 3/10

23-09-2026

PRA Group, Inc. announced that Owen James, President of PRA Group Europe, will retire from his role effective December 31, 2026, and will serve in an advisory capacity until March 31, 2027 to ensure a smooth transition. The filing does not include any financial results or performance metrics.

  • · Owen James notified the company of his retirement on September 21, 2026.
  • · His retirement as President of PRA Group Europe is effective December 31, 2026.
  • · He will serve in an advisory role from January 1, 2027 through March 31, 2027.
WELLS FARGO & COMPANY/MN 8-K neutral materiality 3/10

23-09-2026

Wells Fargo & Company announced the appointment of Scott E. Powell as Chief Risk Officer, effective January 15, 2027, after which he will no longer serve as Chief Operating Officer. The filing contains no financial data or period-over-period comparisons.

TransUnion 8-K neutral materiality 6/10

23-09-2026

TransUnion (NYSE: TRU) announced that CFO Todd Cello will step down on December 31, 2026, after 29 years with the company, including nine years as CFO. He will serve as a full-time advisor through March 1, 2027, to ensure a smooth transition. The company has initiated a CFO search with a leading executive search firm and reaffirmed its Q3 and full-year 2026 guidance for revenue, Adjusted EBITDA, and Adjusted Diluted EPS, stating the departure will not impact operations, strategic priorities, or capital allocation.

  • · TransUnion operates in more than 30 countries with over 13,000 associates.
  • · The company reaffirmed its Q3 and full-year 2026 guidance for revenue, Adjusted EBITDA, and Adjusted Diluted EPS.
  • · Cello will remain CFO through December 31, 2026, and serve as a full-time advisor until March 1, 2027.
  • · The CFO search is being conducted in partnership with a leading executive search firm.
OneMedNet Corp 8-K neutral materiality 6/10

23-09-2026

OneMedNet Corporation held its 2026 Annual Meeting on September 18, 2026, where stockholders approved all four proposals, including the election of three Class III directors, ratification of WithumSmith+Brown as independent auditor, an increase in the 2022 Equity Incentive Plan share reserve by 1,000,000 shares, and a reverse stock split authorization (ratio between 1-for-5 and 1-for-20). The reverse stock split proposal passed with strong support (41,068,200 votes for, 739,329 against), while the equity plan amendment received the lowest approval percentage (about 94.6% of votes cast, excluding broker non-votes). The company remains an emerging growth company and has not elected to use the extended transition period for new accounting standards.

  • · The reverse stock split authorization allows the Board to determine a ratio between 1-for-5 and 1-for-20, with no specific ratio selected yet.
  • · The 2022 Plan amendment became effective immediately upon stockholder approval at the Annual Meeting.
  • · The company is an emerging growth company and has not elected to use the extended transition period for complying with new or revised financial accounting standards.
  • · The Annual Meeting was held virtually via live audio webcast.
  • · The proxy statement for the Annual Meeting was filed on August 19, 2026.
LiveOne, Inc. 8-K neutral materiality 5/10

23-09-2026

LiveOne, Inc. held its 2026 Annual Meeting on September 17, 2026, where all seven director nominees were elected and the new 2026 Equity Incentive Plan was approved by stockholders. The plan reserves 4,000,000 shares of common stock and replaces the expired 2016 Equity Incentive Plan. The ratification of Macias Gini & O'Connell, LLP as independent auditor for fiscal year ending March 31, 2027, was also approved with overwhelming support (8,430,988 for, 132,537 against).

  • · The 2026 Equity Incentive Plan was approved with 4,511,114 votes for, 624,075 against, and 20,777 abstained.
  • · All seven director nominees were elected with over 5.1 million votes for each and fewer than 55,000 withheld votes.
  • · The ratification of the independent auditor received 8,430,988 votes for, 132,537 against, and 1,423 abstained.
  • · The proposal to adjourn the Annual Meeting if necessary was approved with 7,985,029 votes for, 573,424 against, and 6,492 abstained.
  • · No awards or shares have been issued under the 2026 Plan as of the filing date.
Sunrise Realty Trust, Inc. 8-K neutral materiality 3/10

23-09-2026

Sunrise Realty Trust, Inc. (SUNS) filed an 8-K on September 23, 2026, disclosing that its Board increased its size to six directors and approved the appointment of Howard Sudnow as an independent director, effective at the closing of the pending merger with Southern Realty Trust Inc. (SRT), expected in Q4 2026. Mr. Sudnow, a Partner at MYST Advisors with over 30 years of capital markets experience, will serve until the 2027 annual meeting. No financial metrics or performance data were included in this filing.

  • · Merger with SRT expected to close in Q4 2026
  • · Mr. Sudnow has not been appointed to any Board committee as of the filing date
  • · Mr. Sudnow has no family relationships with SUNS directors or executive officers
  • · Mr. Sudnow will receive standard non-employee director compensation
  • · Mr. Sudnow's prior roles include Managing Director of Institutional Sales at Seaport Global and similar role at Sterne Agee (2013-2016)
PLUG POWER INC 8-K neutral materiality 4/10

23-09-2026

Plug Power Inc. announced that COO Dean C. Fullerton will resign effective October 23, 2026, to accept a position at another company. The resignation is not due to any disagreement with the company, and Fullerton will assist with transitioning his duties to other executives. The company expressed gratitude for his contributions.

  • · Resignation effective October 23, 2026
  • · Duties to be transitioned to certain Executive Vice Presidents and Vice Presidents
  • · Filing date: September 23, 2026
AParadise Acquisition Corp. 8-K mixed materiality 5/10

23-09-2026

Enhanced Group Inc. (NYSE: ENHA) announced board changes, appointing Mike Sepso (co-founder of Major League Gaming) to the Board and Audit Committee, naming James Simpson Chairman, and Tony Eisenberg Audit Committee Chair. Christian Angermayer and Jim Murren stepped down from the Board but remain in advisory roles; Apeiron Investment Group, the largest shareholder, has been increasing its stake. The changes reflect continuity and fresh expertise, though the departure of two directors signals a shift in governance.

  • · Apeiron Investment Group, Enhanced's largest shareholder, has been increasing its stake continuously over the past weeks.
  • · Mike Sepso co-founded Vindex, a gaming and esports technology infrastructure company acquired by ESL FACEIT Group in 2023.
  • · Jim Murren will serve as Special Advisor to the CEO after stepping down from the Board.
  • · Christian Angermayer remains Co-Founder and continues through Apeiron Investment Group.
Tri-State Generation & Transmission Association, Inc. 8-K neutral materiality 1/10

23-09-2026

Tri-State Generation & Transmission Association, Inc. announced the election of Amy Miller as a director representing Wheatland Rural Electric Association on its Board of Directors, effective September 22, 2026. Mrs. Miller is expected to serve on the External Affairs-Member Relations Committee. This is a routine board appointment with no financial impact disclosed.

IIOT-OXYS, Inc. 8-K neutral materiality 3/10

23-09-2026

IIOT-OXYS, Inc. appointed Vidhyadhar Mitta as a director on September 21, 2026, effective immediately. Mr. Mitta previously served as a director and had entered into a Debt Exchange Agreement in October 2025, exchanging $216,156 of principal and accrued interest for 180 shares of Series E Preferred Stock and canceling 12,000 shares of Series A Preferred Stock. The filing does not include any financial results or period-over-period comparisons.

  • · Mr. Mitta previously served as a director of the Company.
  • · The Board does not have any committees, and Mr. Mitta has not been named to any committee.
  • · The Debt Exchange Agreement was entered into on October 30, 2025, and closed on November 5, 2025.
  • · The 12% Secured Convertible Promissory Note was issued to Mr. Mitta on August 2, 2019.
  • · No other transactions between the Company and Mr. Mitta require disclosure under Item 404(a) of Regulation S-K.
Tivic Health Systems, Inc. 8-K neutral materiality 5/10

23-09-2026

Valion Bio, Inc. (Nasdaq: VBIO) announced the appointment of board member Dean Zikria as Interim CEO, succeeding Sheryle Bolton who stepped down from the Board. Thomas Jensen was appointed Chair of the Board and Compensation Committee, and Jared Malbin was appointed Chair of the Audit Committee. The leadership changes aim to sharpen execution as the company advances its lead candidate Entolimod and evaluates strategic, commercial, and government opportunities. No financial metrics or performance data were disclosed in the filing.

  • · Dean Zikria previously co-invented therapeutics for traumatic brain injury, hemorrhagic shock, and battlefield medicine at Columbia University Medical Center.
  • · He spent seven years at Pfizer in strategy and business development roles within its $7 billion U.S. cardiovascular business.
  • · Lisa Wolf continues as President, COO, and CFO, reporting to Mr. Zikria.
  • · Entolimod has received Fast Track and Orphan Drug designations from the FDA and is being developed under the FDA's Animal Rule.
  • · Valion's subsidiary Velocity Bioworks is a biologics CDMO supporting internal pipeline development.
EDGEWELL PERSONAL CARE Co 8-K neutral materiality 2/10

23-09-2026

Edgewell Personal Care announced that LaTanya Langley will become Chief Administrative and Legal Officer and Corporate Secretary effective October 1, 2026, and will no longer serve as Chief People Officer. No changes to her compensation were disclosed. This is a routine executive role change with no financial impact.

  • · Effective date of role change: October 1, 2026
  • · Ms. Langley will retain the title of Chief Legal Officer (as indicated by her signature block)
  • · No compensation changes in connection with the role change
CORCEPT THERAPEUTICS INC 8-K neutral materiality 5/10

23-09-2026

Corcept Therapeutics announced that Sean Maduck, President of the Endocrinology division, will retire, with Justin Gunn succeeding him effective October 1, 2026. Maduck will remain as a senior commercial advisor to ensure a smooth transition. The leadership change is part of the company's ongoing focus on expanding its Endocrinology business, particularly for Cushing's syndrome.

  • · Justin Gunn joined Corcept in July 2024 as VP of Sales and Commercial Learning for the Oncology division.
  • · Gunn built the field sales and training organization for Lifyorli, approved for platinum-resistant ovarian cancer.
  • · Maduck will serve as senior commercial advisor during the transition.
  • · Corcept has discovered over 1,000 proprietary selective cortisol modulators and glucocorticoid receptor antagonists.
  • · Advanced clinical trials are ongoing in hypercortisolism, solid tumors, ALS, and liver disease.
MeiraGTx Holdings plc 8-K positive materiality 5/10

23-09-2026

MeiraGTx Holdings plc appointed veteran healthcare portfolio manager Alan M. Sebulsky to its Board of Directors, effective September 23, 2026. Mr. Sebulsky brings over 40 years of experience, most recently as Partner and Portfolio Manager at Adage Capital Management, where he oversaw a $2 billion biopharmaceutical portfolio. The appointment is part of MeiraGTx's transformation into a commercial-stage company, with no negative or flat metrics disclosed in this filing.

  • · Mr. Sebulsky reestablished Apothecary Capital in April 2026 and currently serves as Managing Member.
  • · He holds an M.S. in finance and a B.B.A. in finance and economics from the University of Wisconsin–Madison.
  • · MeiraGTx has four late-stage clinical programs targeting the eye, radiation-induced xerostomia, and Parkinson's disease.
  • · The company has two GMP-licensed viral vector production facilities and a GMP QC facility with clinical and commercial licensure.
Central Plains Bancshares, Inc. 8-K neutral materiality 3/10

23-09-2026

Central Plains Bancshares, Inc. (CPBI) extended the employment agreement of its President and CEO, Dannel R. Garness, and the change-in-control agreements for its CFO and Chief Lending Officer through October 24, 2029. The extensions, effective September 22, 2026, involve no other changes to the agreements. This is a routine retention action with no financial figures disclosed.

  • · The extended agreements now expire on October 24, 2029.
  • · No other changes were made to the Employment Agreement or Change in Control Agreements.
  • · The company is an emerging growth company and has not elected to use the extended transition period for complying with new or revised financial accounting standards.
Galaxy Digital Inc. 8-K neutral materiality 3/10

23-09-2026

Galaxy Digital Inc. announced that Robert Rico will resign as Chief Accounting Officer and principal accounting officer effective September 30, 2026, to pursue an opportunity outside the company. Dritan Muneka, currently Head of Accounting Policy, has been appointed as the new PAO with the title Corporate Controller, effective the same date. No compensation arrangements or family relationships were disclosed in connection with the appointment.

  • · Dritan Muneka, age 40, has served as Head of Accounting Policy since May 2022.
  • · Prior to Galaxy, Muneka was at KPMG LLP from November 2010 to April 2022, ending as Managing Director.
  • · Muneka holds a bachelor's degree in economics and a master's degree in international relations from Monash University and is a CPA.
  • · No family relationships or material interests in transactions requiring disclosure under Item 404(a) were reported.
  • · Muneka will enter into the company's standard Indemnification Agreement (Exhibit 10.2 to Form S-4 filed January 28, 2022).

Get daily alerts with 10 investment signals, 9 risk alerts, 9 opportunities and full AI analysis of all 26 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US Corporate Board Director Changes SEC Filings

🇺🇸 More from United States

View all →